Skip to main content
. 2013 Dec 10;2(2):212–218. doi: 10.3892/mco.2013.223

Table IV.

Interval from the end of first-line treatment to relapse according to histological type.

Histology No. of patients Interval from the end of first-line treatment to relapse (months)

<6 6–12 >12
Serous 73 10 (14%) 27 (37%) 36 (49%)
Endometrioid 12 3 (25%) 3 (25%) 6 (50%)
Clear cell 16 5 (31%) 6 (38%) 5 (31%)
Mucinous 6 2 (33%) 1 (17%) 3 (50%)